MAKE CANCER A BENIGN EXPERIENCE
Live / Registered — Registered (as of 23 Jan 2024)
What this means for you
Registered since 23 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90701065
- Registration number
- 7287794
- Mark type
- Stylized text
- Filed
- 10 May 2021
- Published for opposition
- 14 Jun 2022
- Registered
- 23 Jan 2024
- Attorney of record
- Ted D. Karr
Goods and services
- Class 005 — Pharmaceuticals: Products for the prevention of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the localization of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for localization of cancer; Products for the therapy of cancer in humans, namely, pharmaceutical products to express a treatment agent for treating cancer; Products for the prevention of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the therapy of cancer in animals, namely, pharmaceutical products to express a treatment agent for treating cancer
- Class 044 — Medical, beauty and agricultural services: Medical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the localization of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for the localization of cancer; Medical services for the therapy of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for treating cancer; Medical services for the prevention of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the therapy of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for the treatment of cancer
Owner
- Earli Inc., South San Francisco, CA, US
- Earli Inc., South San Francisco, CA, US
- Earli Inc., South San Francisco, CA, US
Prosecution history
- 23 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 19 Dec 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Dec 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Dec 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Dec 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Dec 2023 — ASSIGNED TO LIE
- 07 Jul 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Apr 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Apr 2023 — NON-FINAL ACTION E-MAILED
- 10 Apr 2023 — SU - NON-FINAL ACTION - WRITTEN
- 24 Feb 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Feb 2023 — USE AMENDMENT FILED
- 23 Feb 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Feb 2023 — TEAS STATEMENT OF USE RECEIVED